Huichan He

机构：Guangzhou Experimental Station, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University

发表论文 113 篇 · 总被引 2282 次 · h-index 29

代表论文

• Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer (2023 · Signal Transduction and Targeted Therapy · 被引 22)
• Fluorescent Nanoparticles Achieve Efficient Photothermal Conversion and Enhanced Antitumor Efficacy Through Intermolecular Aggregation‐Caused Quenching (2024 · Aggregate · 被引 21)
• A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy (2024 · International Journal of Nanomedicine · 被引 16)
• Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation (2025 · Cancer Letters · 被引 14)
• ACOX2 Serves as a Favorable Indicator Related to Lipid Metabolism and Oxidative Stress for Biochemical Recurrence in Prostate Cancer (2024 · Journal of Cancer · 被引 13)
• Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer (2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 6)